LATS1 and Alzheimer disease: Additionally, in order to validate the beneficial role of Hippo signaling inhibition for the treatment of AD, different approaches for inhibiting Hippo signaling activity, including both genetic and pharmacological means, should be used to verify the results from 5xFAD mice with KO of Lats1 and Lats2.